Jupiter Neurosciences, Inc. Warrants (JUNSW) Key Ratios
$0.00
As on 08-Feb-2022EDT
Market cap
$-- Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | -- | -- | -- |
| Net Profit | -- | -143.85 | 45.69 | -- | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-20 | Dec-19 | Dec-18 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | 37.92 | -- | -- |
| Return on Capital
| -- | -- | 44.66 | -- | -- |
| Return on Assets
| -- | -- | -595.04 | -- | -- |
| Debt to Equity (x)
| -- | -- | -0.03 | -0.24 | -- |
Profitability
ROCE
44.66
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
44.66
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
37.92
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
37.92
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-595.04
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
-595.04
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-146.92
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
-146.92
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
45.69
--
Year on year growth in profit after tax
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
45.69
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
-0.03
--
Total debt / Net worth
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
-0.03
|
-0.24
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.03
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
-0.03
|
-0.24
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.13
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
0.13
|
0.00
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
11.21
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
11.21
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
4.05
--
Sales / Average Total Assets
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
4.05
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
40.94
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-20
|
Dec-19
|
Dec-18
|
Dec-17
|
Dec-16
|
|---|---|---|---|---|---|
|
Jupiter Neurosciences, Inc. Warrants (JUNSW)
|
40.94
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|